Tocilizumab for giant cell arteritis: successful treatment with the occurrence of autoimmune thyreoiditis

被引：0
|
作者：
Jaspers, C. [1 ]
Reinbold, W. [2 ]
Turkiewicz, R. [3 ]
Lakomek, H. [4 ]
机构：
[1] Johannes Wesling Klinikum Minden, Klin Rheumatol & Endokrinol, Minden, Germany
[2] Johannes Wesling Klinikum Minden, Inst Radiol Nukl Med, Minden, Germany
[3] Johannes Wesling Klinikum Minden, Klin Pneumol, Minden, Germany
[4] Johannes Wesling Klinikum Minden, Klin Rheumatol & Geriatrie, Minden, Germany
来源：
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [31] Tocilizumab for giant cell arteritis: an amazing result
    Metin Işık
    Levent Kılıç
    İsmail Doğan
    Meral Çalgüneri
    Rheumatology International, 2013, 33 : 2961 - 2962
  • [32] Trial of Tocilizumab in Giant-Cell Arteritis
    Stone, J. H.
    Tuckwell, K.
    Dimonaco, S.
    Klearman, M.
    Aringer, M.
    Blockmans, D.
    Brouwer, E.
    Cid, M. C.
    Dasgupta, B.
    Rech, J.
    Salvarani, C.
    Schett, G.
    Schulze-Koops, H.
    Spiera, R.
    Unizony, S. H.
    Collinson, N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (04): : 317 - 328
  • [33] Tocilizumab for giant cell arteritis: an amazing result
    Isik, Metin
    Kilic, Levent
    Dogan, Ismail
    Calguneri, Meral
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) : 2961 - 2962
  • [34] TREATMENT OF GIANT CELL ARTERITIS WITH TOCILIZUMAB: A RETROSPECTIVE COHORT STUDY OF 119 PATIENTS
    Rakholiya, J.
    Koster, M.
    Langenfeld, H.
    Crowson, C. S.
    Abril, A.
    Bansal, P.
    Mertz, L.
    Rodriguez-Pla, A.
    Sehgal, R.
    Wang, B.
    Warrington, K. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 655 - 655
  • [35] Progression of large-vessel giant cell arteritis despite tocilizumab treatment
    Elfishawi, M.
    Kaymakci, M.
    Koster, M. J.
    Warrington, K. J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (04) : 984 - 985
  • [36] Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
    Samson, Maxime
    Greigert, Helene
    Ciudad, Marion
    Gerard, Claire
    Ghesquiere, Thibault
    Trad, Malika
    Corbera-Bellalta, Marc
    Genet, Coraline
    Ouandji, Sethi
    Cladiere, Claudie
    Thebault, Marine
    Ly, Kim Heang
    Liozon, Eric
    Maurier, Francois
    Bienvenu, Boris
    Terrier, Benjamin
    Guillevin, Loic
    Charles, Pierre
    Quipourt, Valerie
    Devilliers, Herve
    Gabrielle, Pierre-Henry
    Creuzot-Garcher, Catherine
    Tarris, Georges
    Martin, Laurent
    Saas, Philippe
    Audia, Sylvain
    Cid, Maria Cinta
    Bonnotte, Bernard
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (09)
  • [37] TOCILIZUMAB VERSUS PREDNISOLONE ONLY TREATMENT FOR GIANT CELL ARTERITIS: AN OBSERVATIONAL STUDY
    Preston, Hannah
    Cronin, Owen
    Kuske, Barbara
    McKay, Neil D.
    Hauser, Barbara
    RHEUMATOLOGY, 2021, 60
  • [38] Comment on: Development of intracranial vasculitis in giant cell arteritis during tocilizumab treatment
    Koster, M. J.
    Warrington, K. J.
    Lehman, V. T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) : S198 - S198
  • [39] Treatment of Giant Cell Arteritis with Tocilizumab: A Retrospective Cohort Study of 119 Patients
    Rakholiya, Jigisha
    Koster, Matthew
    Langenfeld, Hannah
    Crowson, Cynthia
    Abril, Andy
    Bansal, Pankaj
    Mertz, Lester
    Pla, Alicia Rodriguez
    Sehgal, Rahul
    Wang, Benjamin
    Warrington, Kenneth
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2923 - 2925
  • [40] Tocilizumab for the Treatment of Giant Cell Arteritis - a Randomized Placebo-Controlled Trial
    Adler, Sabine
    Reichenbach, Stephan
    Kuchen, Stefan
    Wermelinger, Felix
    Dan, Diana
    Villiger, Peter M.
    Seitz, Michael
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
12345